Clinical study on the usefullness of edoxaban tosilate hydrate to portal vein thrombosis complicated with chronic liver disease
Phase of Trial: Phase IV
Latest Information Update: 29 May 2019
Price : $35 *
At a glance
- Drugs Edoxaban (Primary)
- Indications Venous thrombosis
- Focus Therapeutic Use
- Acronyms PVTED study
- 27 May 2019 Status changed from recruiting to discontinued.
- 18 Dec 2017 Status changed from not yet recruiting to recruiting.
- 27 Nov 2017 New trial record